Tissue Regeneration Market Expected to Exceed +35.0% of CAGR Globally by Components, Raw Material, Application and Key Players Analysis by 2024
Top vendors operating in Tissue Regeneration Market are Arteriocyte Medical Systems Inc., Athersys Inc., Cerapedics Inc., Co. Don AG, Cook Medical Inc., Cryolife Inc., Cytori Therapeutics Inc., Genzyme Corp. and Kinetic Concepts Inc. by 2024
Pune, India -- (SBWire) -- 01/12/2018 --According to the new research report titled Global Tissue Regeneration Market 2017-2024 By Components (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Existing and Development-stage Stem Cell Products, Tissue Vascularization, Cell Culturing, Small Molecules and Biologics, Others), By Raw Material (Synthetic, Genetically Modified, Biological), By Application (Cardiovascular Disorders, Oncology, Dermatology, Musculoskeletal, Wound Healing, Neurology, Ophthalmology, Others), By End User (Hospitals, Clinics, Ambulatory Centers, and Laboratories) By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Global Tissue Regeneration Market accounted to USD 13.5 billion in 2016 growing at a CAGR of 35.0% during the forecast period of 2017 to 2024.
This report consists of below pages:
- No of pages: 350
- No of Figures: 60
- No of Tables: 220
Get Free Sample Copy of this Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-tissue-regeneration-market
Tissue regeneration is the process of development of tissues and organs. The method involves application of engineering of tissue substitutes which maintain, restore and improve the function of defective or ruptured tissue.
Major Market Drivers and Restraints:
- Rising cost of organ transplantation
- Increasing medical applications of 3D printing in tissue and organ regeneration
- Stringent government regulations
- High initial costs
- Lack of knowledge and skilled professionals
Report Segmentation:
By components, the tissue regeneration market is segmented into cell therapy, stem cell therapy, stem cell sources, existing and development-stage stem cell products, tissue vascularization, cell culturing, small molecules and biologics, others.
Based on raw material the tissue regeneration market is segmented into synthetic, genetically modified, biological.
On the basis of application the market is segmented into cardiovascular disorders, oncology, dermatology, musculoskeletal, wound healing, neurology, ophthalmology, others.
Based on end-users the tissue regeneration market is segmented into hospitals, clinics, ambulatory centers, research laboratories and others.
Read more about the Global Tissue Regeneration Market Report Visit @ http://databridgemarketresearch.com/reports/global-tissue-regeneration-market/
On the basis of geography, tissue regeneration market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis:
The Global Tissue Regeneration Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of tissue regeneration market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors:
Some of the major players operating in tissue regeneration market are Arteriocyte Medical Systems Inc., Athersys Inc., Cerapedics Inc., Co. Don AG, Cook Medical Inc., Cryolife Inc., Cytori Therapeutics Inc., Genzyme Corp., Kinetic Concepts Inc., Mesoblast Ltd., Nuo Therapeutics Inc., Ocata Therapeutics Inc., Organogenesis Inc., Orthopeutics L.P., U.S. Stem Cell Inc., Vericel Corp. , Wright Medical Group N.V among others.
Order a copy of Tissue Regeneration Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tissue-regeneration-market
Related Report
Global Intra-Uterine Contraceptive Devices Market – Industry Trends and Forecast to 2024
Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/
Media Relations Contact
Sopan Gedam
Manager
Data Bridge Market Research
888-387-2818
http://databridgemarketresearch.com/reports/global-tissue-regeneration-market/
View this press release online at: http://rwire.com/915398